BeOne Medicines (ONC) PT Raised to $420 at Jefferies
Tweet Send to a Friend
Jefferies analyst Kelly Shi raised the price target on BeOne Medicines (NASDAQ: ONC) to $420.00 (from $398.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
